These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32391255)

  • 41. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
    Liu K; Han Y; Ma B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Sun Y; Yu XL; Luo W; Lee AW; Wee JT; Lee N; Zhou GQ; Tang LL; Tao CJ; Guo R; Mao YP; Zhang R; Guo Y; Ma J
    Radiother Oncol; 2014 Mar; 110(3):390-7. PubMed ID: 24721546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy.
    Hsiung CY; Ting HM; Huang HY; Lee CH; Huang EY; Hsu HC
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):454-61. PubMed ID: 16839707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
    McDowell LJ; Ringash J; Xu W; Chan B; Lu L; Waldron J; Rock K; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Bernstein LJ
    Radiother Oncol; 2019 Feb; 131():179-185. PubMed ID: 30279047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus.
    Hsiung CY; Huang EY; Ting HM; Huang HY
    Br J Radiol; 2008 Oct; 81(970):809-14. PubMed ID: 18591201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olfactory change after intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Wang JJ; Liang KL; Twu CW; Lin JC; Jiang RS
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1059-62. PubMed ID: 26077632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity.
    Sun PY; Chen YH; Feng XB; Yang CX; Wu F; Wang RS
    Med Sci Monit; 2018 Dec; 24():8849-8859. PubMed ID: 30524119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy.
    Takiar V; Ma D; Garden AS; Li J; Rosenthal DI; Beadle BM; Frank SJ; Fuller CD; Gunn GB; Morrison WH; Hutcheson K; El-Naggar AK; Gold KA; Kupferman ME; Phan J
    Head Neck; 2016 Apr; 38 Suppl 1():E925-33. PubMed ID: 25994561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma.
    Prayongrat A; Chakkabat C; Kannarunimit D; Hansasuta P; Lertbutsayanukul C
    J Radiat Res; 2017 Jul; 58(4):509-516. PubMed ID: 28204596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive function, mood, and sleep quality in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer: a prospective study.
    Mo YL; Li L; Qin L; Zhu XD; Qu S; Liang X; Wei ZJ
    Psychooncology; 2014 Oct; 23(10):1185-91. PubMed ID: 24729515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
    Peng G; Wang T; Yang KY; Zhang S; Zhang T; Li Q; Han J; Wu G
    Radiother Oncol; 2012 Sep; 104(3):286-93. PubMed ID: 22995588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
    Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
    BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasopharyngeal carcinoma treated with precision-oriented radiation therapy techniques including intensity-modulated radiotherapy: preliminary results.
    Liu WS; Su MC; Wu MF; Tseng HC; Kuo HC
    Kaohsiung J Med Sci; 2004 Feb; 20(2):49-55. PubMed ID: 15481551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
    Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
    Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.